EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 5, 2014, Pages 2372-2381

  Lin, Chien Hung ^a,b   Chao, Li Keng ^a,c   Hung, Peir Haur ^d   Chen, Yann Jang ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

EGCG; Nasopharyngeal cancer; STAT3

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHIN; CISPLATIN; EPIGALLOCATECHIN GALLATE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CANCER STEM CELL; CELL PROLIFERATION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MULTICELLULAR SPHEROID; NASOPHARYNX TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS;

EID: 84902436518     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hildesheim A and Wang CP. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Semin Cancer Biol 2012; 22: 107-116.
2. Lo KW, To KF and Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004; 5: 423-428.
3. Dalerba P, Cho RW and Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med 2007; 58: 267-284.
4. Lara-Padilla E and Caceres-Cortes JR. On the nature of the tumor-initiating cell. Curr Stem Cell Res Ther 2012; 7: 26-35.
5. Frame FM and Maitland NJ. Cancer stem cells, models of study and implications of therapy resistance mechanisms. Adv Exp Med Biol 2011; 720: 105-118.
6. Sampieri K and Fodde R. Cancer stem cells and metastasis. Semin Cancer Biol 2012; 22: 187-193.
7. Chen SF, Chang YC, Nieh S, Liu CL, Yang CY and Lin YS. Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties. PLoS One 2012; 7: e31864.
8. Wang S, Huang S, Zhao X, Zhang Q, Wu M, Sun F, Han G and Wu D. Enrichment of prostate cancer stem cells from primary prostate cancer cultures of biopsy samples. Int J Clin Exp Pathol 2014; 7: 184-193.
9. Zhou W, Kallifatidis G, Baumann B, Rausch V, Mattern J, Gladkich J, Giese N, Moldenhauer G, Wirth T, Buchler MW, Salnikov AV and Herr I. Dietary polyphenol quercetin targets pancreatic cancer stem cells. Int J Oncol 2010; 37: 551-561.
10. Link A, Balaguer F, Shen Y, Lozano JJ, Leung HC, Boland CR and Goel A. Curcumin modulates DNA methylation in colorectal cancer cells. PLoS One 2013; 8: e57709.
11. Hu FW, Tsai LL, Yu CH, Chen PN, Chou MY and Yu CC. Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Mol Nutr Food Res 2012; 56: 1247-1258.
12. Chen D, Pamu S, Cui Q, Chan TH and Dou QP. Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells. Bioorg Med Chem 2012; 20: 3031-3037.
13. Singh BN, Shankar S and Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EG-CG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011; 82: 1807-1821.
14. Yang CS, Wang X, Lu G and Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009; 9: 429-439.
15. Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q, Choi GC, Au TC, Ho K, Yau DM, Ma BB, Hui EP, Chan AS, Tsang CM, Tsao SW, Grandis JR and Chan AT. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int J Cancer 2009; 125: 1884-1893.
16. Schroeder A, Herrmann A, Cherryholmes G, Kowolik C, Buettner R, Pal S, Yu H, Mueller-Newen G and Jove R. Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling. Cancer Res 2014; 74: 1227-37.
17. Ho PL, Lay EJ, Jian W, Parra D and Chan KS. Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. Cancer Res 2012; 72: 3135-3142.
18. Kawasaki BT, Hurt EM, Mistree T and Farrar WL. Targeting cancer stem cells with phytochemicals. Mol Interv 2008; 8: 174-184.
19. Burnett J, Newman B and Sun D. Targeting Cancer Stem Cells with Natural Products. Curr Drug Targets 2012; 13: 1054-64.
20. Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, Mrabti H, Boussen H and Errihani H. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis 2011; 128: 79-85.
21. Liotta LA and Kohn E. Anoikis: cancer and the homeless cell. Nature 2004; 430: 973-974.
22. Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici P, Konda B, Wachsmann-Hogiu S, Black KL and Yu JS. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 2007; 25: 1645-1653.
23. Wang X, Wang G, Zhao Y, Liu X, Ding Q, Shi J, Ding Y and Wang S. STAT3 mediates resistance of CD44(+)CD24(-/low) breast cancer stem cells to tamoxifen in vitro. J Biomed Res 2012; 26: 325-335.
24. Lin L, Fuchs J, Li C, Olson V, Bekaii-Saab T and Lin J. STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH(+)/CD133(+) stem cell-like human colon cancer cells. Biochem Biophys Res Commun 2011; 416: 246-251.
25. Peyser ND and Grandis JR. Critical analysis of the potential for targeting STAT3 in human malignancy. Onco Targets Ther 2013; 6: 999-1010.
26. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, Margolick JB, Liotta LA, Petricoin E 3rd and Zhang Y. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 2007; 104: 16158-16163.
27. Gupta S, Hastak K, Afaq F, Ahmad N and Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 2004; 23: 2507-2522.
28. Manna S, Mukherjee S, Roy A, Das S and Panda CK. Tea polyphenols can restrict benzo[a]pyrene-induced lung carcinogenesis by altered expression of p53-associated genes and H-ras, c-myc and cyclin D1. J Nutr Biochem 2009; 20: 337-349.